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Experimental colitis induced by acetic acid has been used extensively as a model for intestinal inflammatory disease.
Colonic tissue lesions of intestinal inflammatory disease patients seem to be related to the increased local production of pro-
inflammatory cytokines (IL-1, IL-6, TNF-?, and IFN-?).
PURPOSE: To assess the cytokine expression pattern identified through immunohistochemistry in colonic mucosa after
experimental colitis induced by acetic acid and establish the relationship between this pattern and the presence of macroscopic
lesions.
MATERIALS AND METHODS: Adult male Wistar rats (n = 39) were divided at random into 4 groups: NC45 and NC24
(control without colitis; sacrificed at 45 minutes and 24 hours, respectively); and WC45 and WC24 (with experimental
colitis induced by acetic acid; sacrificed at 45 minutes and 24 hours, respectively). Macroscopic and microscopic alterations
in colonic tissue were evaluated, and cytokine expression was assessed through immunohistochemistry.
RESULTS: After 24 hours, IL-1 expression was greater in the groups with colitis when compared to the groups without
colitis. IL-4 expression was higher in the WC45 group. There was an increase in both INF-? and IL-6 related to the presence
of necrosis of the colonic mucosa in the groups with colitis for both periods evaluated.
CONCLUSION: The immunohistochemical technique was efficient for the analysis of various cytokine expressions in the
colonic tissue. There was an increase in the IL-1 pro-inflammatory cytokines as well as in IL-6 and IFN-? associated with the
presence of colonic necrosis. Experimental colitis induced by acetic acid is a useful model for the development of studies
assessing the role of cytokines in the inflammation of mucosa as well as anti-cytokine therapies.
KEYWORDS: Cytokines. Rats. Inflammatory colitis. Immunohistochemistry. Necrosis.
The role of cytokines in the immune system within the
colonic mucosa has been extensively assessed in both ex-
perimental and clinical studies.1,2 In such studies, cytokines
are considered determinants of the nature of the mucosal
immune response. Cytokines synthesized and secreted by
defense cells of the lamina propria either induce, amplify
and prolong (pro-inflammatory), or attenuate (anti-inflam-
matory) the inflammatory process.3 An imbalance has been
found between pro-inflammatory and anti-inflammatory
cytokines in intestinal inflammatory disease (IID), with in-
creased levels of interleukin (IL) pro-inflammatory
cytokines IL-1, IL-6, IL-8, and tumor necrosis factor (TNF-
?).1,2,4,5 A greater IL-1:IL-1ra ratio has also been shown in
mucosae of patients with Crohn’s disease, ulcerative coli-
tis, diverticulitis, and infectious colitis.6-8
The increase of pro-inflammatory cytokines among IID
patients can be accompanied by local and systemic tissue
damage, indicating an important role of these inflammatory
mediators in determining the severity of the disease. Local
increases occur in microvascular permeability with conse-
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quent vascular congestion and edema;9 production of other
cytokines is also induced, as well as activation of the vas-
cular endothelium, recruitment of inflammatory cells, and
activation of the coagulation system.10
Attempts to reproduce experimental inflammatory dis-
ease in the colon have generated a number of acute or
chronic inflammation models.11 Currently, models of exog-
enous induction of experimental colitis have been used
more extensively due to their technical simplicity, repro-
ducibility, and lower cost. The most frequently used agents
are acetic acid,12-18 ethanol,19,20 dextran sodium sulfate,21 in-
domethacin,22 and TNBS/ethanol.18,23-26
While the IID inflammatory process in humans is prob-
ably the result of a disordered immunological activation,
experimental colitis induced by exogenous agents is un-
leashed, at least at first, by local tissue lesions. Nonethe-
less, the inhibition of pro-inflammatory cytokines or the
administration anti-inflammatory cytokines in experimen-
tal colitis models induced by dextran sodium sulfate (DSS)
or by trinitrobenzene sulfonic acid (TNBS) reduces colonic
inflammation, indicating that these models seem to repro-
duce the increase in the pro-inflammatory cytokine expres-
sion found in IID patients.27-29
The use of acetic acid provokes nonspecific inflamma-
tion similar to ulcerative colitis,12,14,15,30 with easily repro-
ducible lesions and low mortality.14 An understanding of
the cytokine expression pattern in the colonic mucosa af-
ter the induction of colitis by endoanal infusion with ace-
tic acid, as well as its influence on the appearance or ag-
gravation of consequent macroscopic lesions in the colonic
mucosa, could contribute to the comprehension of its ac-
curacy as a model for human colitis with regard to immu-
nological alterations.
In experimental models, the appearance of inflammatory
cytokines occurs in distinct periods. Some models present
elevations in cytokine levels just minutes after the aggres-
sor stimulus, whereas in others, the elevations occur at a
later time.9,31,32 Cytokine kinetics should therefore be con-
sidered in studies that assess cytokine expression.
Cytokine analysis is generally carried out in a system-
atic fashion. The development of an immunohistochemi-
cal technique applied to the colonic tissue allows the di-
rect demonstration of cells that express different cytokines
at the site of the aggression.
The objective of the present study was to assess the
cytokine expression pattern in colonic tissue after the induc-
tion of experimental colitis through endoanal infusion of ace-
tic acid, and to relate the cytokine to the presence of clini-
cal lesions characteristic of intestinal inflammatory disease,
using an immunohistochemical technique developed specifi-
cally for this purpose.
MATERIALS AND METHODS
Animals
A total of 39 adult male Wistar rats (Rattus norvegicus
albinus), weighing between 250 and 300 grams were acquired
from the Central Animal Breeding Center of the Faculty of
Medicine, University of São Paulo Medical School (FMUSP).
The animals were housed in individual metabolic cages, with
water and pellet ration ad libitum. They were kept at room
temperature and under diurnal light cycles at the Laboratório
de Fisiologia e Distúrbios Esfincterianos, FMUSP – LIM 35.
Elimination of intestinal parasites
Before initiating the experimental procedures, all animals
were treated with two vermifuges: Praziquantel (Cestox® -
Merck Sharp Dohme) at a dosage of 25 mg/kg of weight;
and Ivermectin/Pirantel (Ivomec® - Merck Sharp Dohme) at
2.0 mg/kg of weight. Both vermifuges were mixed with 10%
propylene glycol and administered orally in 3 doses at 7-
day intervals for 2 weeks before the experiment.
Colitis induction
The animals were randomly divided into 2 groups—a
group for induction of experimental colitis and a control
group. In the colitis group, induction of the inflammatory
process of the colon was achieved through a 0.5 mL rectal
injection of 10% acetic acid through a 1 mL sterile syringe
coupled to a No. 6 polyethylene catheter, externally lubri-
cated with lidocaine gel. The catheter was introduced anally
to a distance of 7 cm, in accordance with the standard method
of this laboratory.18 The animals in the control group received
an endoanal infusion of 1 mL normal saline solution.
Experimental groups
After the endoanal infusion of acetic acid (experimen-
tal group) or physiological solution (control group), the ani-
mals in both groups were subdivided for sacrifice at 45 min-
utes or 24 hours after colitis induction. Thus, the resulting
subgroups were composed as follows:
NC45—Animals without colitis, sacrificed 45 minutes
after endoanal infusion of saline solution (n = 9);
NC24—Animals without colitis, sacrificed 24 hours af-
ter endoanal infusion of saline solution (n = 10);
WC45—Animals with colitis, sacrificed 45 minutes af-
ter endoanal infusion of acetic acid (n = 10);
WC24—Animals with colitis, sacrificed 24 hours after
endoanal infusion of acetic acid (n = 10).
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Collection of biological material and sacrifice
Prior to the sacrifice, the animals were anesthetized
through an intraperitoneal injection of 100 mg/kg body
weight of ketamine chlorohydrate (Ketalar® - Parke-Davis).
After anesthesia, a laparotomy was performed for inspec-
tion of the abdominal cavity and complete resection of the
large intestine (from the rectum to the transition with the
small intestine). Animals were subsequently sacrificed by
an anesthetic overdose. The colons were rinsed with 20 mL
of saline solution and opened longitudinally for macro-
scopic analysis, collection of biological samples, micro-
scopic analysis and determination of cytokine expression.
Macroscopic analysis of the colon
Macroscopic alterations in the colonic mucosa were clas-
sified into 5 grades, according to the system described by
Moraes14,15, modified by Campos18 (Table 1).
The presence of the following alterations was investi-
gated: dilatation and thickening of the colon walls or small
intestine, the formation of adherences to the small intes-
tine or the epiploon; thickening of the mesentery (mesenteri-
tis); and perforation of the colon. During macroscopic exam
of the colonic tissue, additional attention was given to the
serosa that covers the length of the organ. Disorders were
identified, such as segmental hyperemia of the colon, char-
acterized by a focal increase of red coloration and the pres-
ence of vascular ectasia; edema of the colonic wall, char-
acterized by a thickening of the wall by liquid; ischemia,
characterized by pallor in the serosa that covers the colon;
and necrosis, characterized by a change in the coloration
of the colon segment.
Microscopic analysis of the colon
After macroscopic assessment of the mucosa, 2 samples
of 4 cm each were taken from the colon segments and iden-
tified as fragments A and B. Fragment A was harvested ap-
proximately 5 cm from the distal edge where the macro-
scopic alterations caused by the inflammatory process were
located. Fragment B was collected from the more proximal
region, 5 cm above the macroscopically altered region, con-
taining macroscopically normal mucosa. The selected sam-
ples were separated into previously labeled bottles and
fixed in 10% buffered formalin and later embedded in par-
affin. Thin sections (3 µm) were cut from these blocks and
mounted on histological slides. One slide was stained with
hematoxylin and eosin for histopathological evaluation.
The other slides to be used for the immunohistochemical
reactions were previously treated with 3-amino-
propyltriethoxysilane (Sigma-A3648, EUA).
Histological analysis of the intestinal morphology em-
phasized alterations regarding the integrity and inflamma-
tion of colonic mucosa and submucosa, the presence of ul-
cers, and tissue necrosis. According to our previous re-
sults,18 the histological variables evaluated were: presence
of reactive lymphoid hyperplasia (considered as focal ag-
gregate of lymphoid inflammatory cells in the lamina pro-
pria); epithelial exulceration (superficial or partial exfolia-
tion of colonic epithelial cells without complete ulceration);
ulceration (loss of epithelial layer, covered by fibrin and
neutrophilic debris, sometimes with exposition of submu-
cosa and muscular layer); presence of inflammatory infil-
trate in the intestinal wall (infiltrate extension that was re-
stricted to submucosa, to the muscular layer, or present
through the intestinal wall); and finally presence of trans-
mural necrosis (death of cellular components of all layers
of the intestinal wall). Exulceration, ulcer, and transmural
necrosis reflect progressive categorization of intestinal in-
volvement. All results were stored in an individual data file,
and later correlated to other macroscopic and immunohis-
tochemical results.
Analysis of cytokine expression in the colon
The following cytokines were evaluated in the present
study: IL-1, IL-4, IL-6, IFN-?, and TNF-?. To determine
cytokine expression in the colonic mucosa, an immunohis-
tochemical technique was initially standardized at the Im-
munohistochemistry Laboratory of the Division of Pathol-
ogy of Instituto Adolfo Lutz (São Paulo, Brazil) and re-
sulted in the following protocol:
The histological samples underwent standard processing
and were embedded in paraffin. Tissue sections were adhered
Table 1 – Classification of macroscopic alterations in the
colonic mucosa
GRADE MACROSCOPIC FEATURES
0 Preserved mucosal layer, folding with
normal aspect
I Edema, congestion and reddish areas
without superficial ulceration
II Linear superficial ulcerations (7-15 mm);
areas with depressed, reddish, or darker
mucosal, granular bottom
III Ulcerated area (15 to 45 mm) with irregular
bottom, granular with rounded shaped
island of normal or edematous mucosa
among ulcerated mucosa
IV Extensive, irregular and multiple ulcers
(>45 mm); thinned intestinal wall; granular
irregular bottom.
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to glass slides treated with 3-aminopropyltriethoxysilane,
were deparaffinized, and then were rehydrated. Tissue sec-
tions from 7 blocks from each animal were prepared.
For antigen recuperation, a humid heat technique was
used with a pressure cooker (Eterna®, Nigro) and a 10 mM
citric acid solution (J.T.Baker-0118-01, Mexico) at 6.0 pH
for 4 minutes. The samples were rinsed in running water
and distilled water.
The natural endogenous peroxidase was blocked with
four 5-minute baths of hydrogen peroxide (20 volumes), and
the slides were rinsed in running water and PBS buffer.
The primary specific antibodies for the cytokines stud-
ied were diluted 1:300 with PBS for anti-rIL-1? and 1:30 for
anti-rIL-4, anti-rIL-6, anti-rIFN-?, and anti-rTNF-?. Slides
were incubated with primary antibodies in a chamber at 4°C.
After incubation, the slides were processed by 3 rinses
in PBS buffer and incubated for 30 minutes at 370C with
the biotinylated secondary antibody (Vector-BA5000,
USA) diluted 1:500 with PBS buffer + 0.1% saponin.
Three additional rinses with PBS buffer preceded incu-
bation with strept-avidin-peroxidase (StreptABComplex/
HRP - Dako A/S-K0377, Denmark), diluted at a proportion
of 1:200 (PBS + 0.1% saponin), for 30 minutes at 370C.
Positive revelation of the cytokines was achieved by a
5-minute incubation at 370C with 60 mg% of chromogen
3,3’-diaminobenzidine tetrahydrochloride (DAB - Sigma-
D5637, USA).
Counterstaining with Harris’ hematoxylin for 1 minute
was followed by an additional rinsing in running water and
distilled water, and differentiation in ammoniacal water.
Dehydration of the histological sections proceeded with
increasing concentrations of alcohol and xylol for the fi-
nal mounting of the slides with cover glass and Entellan
(Merck-7961, Germany).
The efficiency of the immunohistochemical reaction was
verified with negative and positive controls. Each slide sub-
mitted to immunohistochemical assay had two 5 mm cop-
ies; one received the studied antibody, and the other re-
ceived bone serum albumin as negative control. Positive
controls were amygdalitis tissue blocks.
Evaluation of cytokine expression of the
immunohistochemical reaction
The slides resulting from the immunohistochemical re-
action were evaluated individually and independently by two
observers in a double-blind manner. Each observer defined
10 fields in an optical microscope (NIKON - JAPAN), at a
magnification of 400x, in areas of greater concentration of
positive inflammatory cells. In each field, the inflammatory
cells in the corium with distinctive strong positivity for the
immunohistochemical reaction were counted. Stromal and
epithelial cells were not considered. The evaluation resulted
in 10 absolute values that led to the absolute number per
slide after calculating the arithmetic mean. Finally, the mean
of the two observers was used for the final result of the reac-
tion. Figure 1 shows positive and negative examples of the
immunohistochemical reactions for TNF-?.
Figure 2 - Microscopic aspects with H & E stain: A—normal mucosa; B—ulceration of colonic mucosa; and C—transmural necrosis
Figure 1 - Negative (A) and positive (B) example of the immunohistochemical reactions for TNF-? in rat colon - 400x
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Statistical Analysis
The results obtained were submitted to statistical analysis
through the Student t test for analysis of the macroscopic and
microscopic variables and cytokine expression in the colonic
mucosa, as well as the Fisher exact test to assess possible cor-
relations between the cytokine expression and macroscopic
alterations. The 95% significance level was adopted (P <.05).
RESULTS
Macroscopic alterations
Macroscopic alterations of the abdominal cavity, such
as adherences and distention of the intestinal loops and
morphological signs of inflammation of the colonic mucosa
and serosa, were only observed in the animals subjected to
colitis. The macroscopic evaluation results for all groups
are provided in Table 2.
Microscopic alterations
The presence of inflammatory cells in the intestinal mu-
cosa was observed in nearly all the animals subjected to
experimental colitis, as well as in some animals without
colitis. The most frequent microscopic alteration was evi-
dence of focal reactional lymphoid hyperplasia.
Exulceration, ulceration, and necrosis were observed exclu-
sively in animals subjected to colitis (Table 3).
Cytokine expression
Data referring to cytokine expression for the various pe-
riods studied are shown in Table 4.
IL-1 presented increased expression in the group with
colitis when compared to the groups without colitis after
24 hours.
In the colonic tissue of animals with colitis, expression
of IL-4 was lower in the WC24 group when compared to
the WC45 group.
There was a greater expression of IL-6 and INF-? in ani-
mals subjected to colitis when compared to the control
groups, with no differences between the periods studied.
The greater expression of INF-? and IL-6 in the presence of
colitis was directly associated to the presence of necrosis
in the colonic mucosa after the 24-hour period (Table 5).
TNF-? was the most frequently expressed cytokine in
the colonic mucosa in the animals from the experimental
Table 4 - Distribution of mean cell positivity of cytokines (IL-1, 4, 6, TNF-? and IFN-?) in groups both with and without
colitis at the different time periods of the experiment
Group IL-1 IL-4 IL-6 TNF-? INF-?
NC45 5.42 ± 2.01 8.81 ± 3.85 2.60 ± 0.65 15.74 ± 9.25 4.39 ± 3.62
WC45 2.90 ± 0.07 11.05 ± 1.91 8.08 ± 2.51 14.50 ± 8.58 6.85 ± 1.70
NC24 5.51 ± 3.04 6.33 ± 0.84 2.71 ± 0.92 15.78 ± 5.70 1.97 ± 0.81
WC24 9.29 ± 4.26 7.92 ± 3.90 8.71 ± 2.20 16.55 ± 7.21 5.51 ± 2.06
NC45 x WC45 * P = .0017 P = .22 * P = .0002 P = .06 * P = .03
NC24 x WC24 * P = .03 P = .25 * P £.001 P = .71 * P = .0004
NC45 x NC24 P = .72 P = .08 P = .90 P =.85 P = 0.06
WC45 x WC24 * P = .0014 * P = .04 P = .60 P = .29 P = .11
* (P <.05) Student t test; Data expressed as mean ± standard deviation; Caption: WC45 = Group with colitis 45 minutes (n =10); NC45 = group
without colitis 45 minutes (n = 9); WC24 = Group with colitis 24 hours (n =10); NC24 = Group without colitis 24 hours (n =10)
Table 3 - Classification of the microscopic alterations at
sacrifice 45 minutes and 24 hours after inducing colitis
Without colitis With colitis
45 min 24 h 45 min 24 h
Lymphoid hyperplasia 5 8 8 5
Exulceration 0 0 9 7
Ulcer 0 0 1 8
Submucosa
inflammatory infiltrate 2 2 8 9
 Muscular
inflammatory infiltrate 1 1 2 6
Transmural necrosis 0 0 0 4
Table 2 - Classification of the abdominal cavity macroscopic
alterations at sacrifice 45 minutes and 24 hours after inducing
colitis
Without colitis With colitis
45 min 24 h 45 min 24 h
Gut Adherences 0 0 1 10
Gut distention 0 0 3 4
Hyperemia 0 0 5 2
Ischemia with
mucosal detachment 0 0 0 7
Ulcer 0 0 5 9
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groups as well as the control groups and for both periods
studied.
DISCUSSION
One of the advantages of conducting studies in experi-
mental models is the possibility of comparing controlled
observations both before and after events, where clinical
observation encounters ethical barriers. Wistar albino rats
have been widely used in metabolism and nutrition stud-
ies33-35 due to the ease in handling and follow-up.
The model of induced colitis through acetic acid en-
emas presents advantages over other experimental models
of this disease. Such advantages include easy availability
of the aggressor reagent, low cost, reproducibility and simi-
larities to IID in humans, principally in terms of histologi-
cal and metabolic aspects.13-15,17,18,35 However, little is known
regarding its similarity in relation to the production of
cytokines in the intestinal mucosa.
Cytokines can be quantified by various methods. Im-
munohistochemistry offers the advantage of directly dem-
onstrating cells in the affected tissue that are secreting the
cytokines under study. The advent of specific antibodies
developed for immunohistochemical reactions, together
with the standardization of a specific method to meet the
objectives of the present study, permitted analysis of the
production of various cytokines in the paraffin-embedded
intestine samples.
The kinetics involved in the appearance of cytokines
underlies the choice of different sacrifice times for the ani-
mals. After aggression, it was expected that the pro-inflam-
matory cytokines would increase in relation to the anti-in-
flammatory cytokines, presenting elevated peaks within
very short periods of time. Later, the pro-inflammatory
cytokines would progressively fall, giving rise to elevation
of anti-inflammatory cytokines.36
Tissue analysis by immunohistochemical method enables
the observation of cytokine expression in multiple points of
different samples, comprising a broader evaluation and some-
times resulting in diverse profiles. The immunochemical as-
say may be repeated many times to confirm previous results.
Serum dosage of cytokine concentration is an accurate
method but usually is not easily reproducible in the same
sample and reflects only a single studied area.
Interleukins may be quantified by distinct methods, no-
tably: radioimmunoassay (ELISA) performed in supernatant
of cultured intestinal epithelial cells or portal and systemic
blood,43 polymorphonuclear cultured cells stimulated by
lipopolysaccharides,37-39 homogenized intestinal tissue,40 IL
cellular RNA quantification in intestinal samples and poly-
morphonuclear cells,39 immunohistochemical evaluation of
IL,41, 42 and DNA analysis after amplification of DNA con-
tent in damaged tissue.44
Any of the plasmatic IL quantification techniques may
be criticized if sample collection or processing methods in-
fluence the expression of a given IL. Moreover, central vein
blood samples may show an IL increase related to other in-
flammatory stimuli that are not necessarily related to bowel
disease. It is recommended that the collection be done in
the vicinity of the aggression. In humans with inflamma-
tory bowel disease, portal vein samples would be ideal,43
although this presents technical difficulties.
Much effort has been made to standardize IL quantifi-
cation methods. Colonic perfusion with a specific electro-
lyte solution enables intestinal lavage that shows suitable
free IL dosage by ELISA.45,46
Immunohistochemical assay directly demonstrates the
IL-expressing cells, but requires viable tissue samples. The
plentiful availability of tissue from experimental models
contrasts to the clinical scenario with limited samples from
biopsies, which frequently are unsuitable for serial immu-
nohistochemical reactions.44
In the present study, there was concern that necrosis, ul-
ceration, or even detachment of the mucosa would be found
in the area directly affected by the aggressor agent (acetic
acid), depending on the local response with nonviable
cells. After the immunohistochemical reactions, we
analyzed a small number of cells that were expressing
cytokines. We also analyzed a second fragment that was ad-
jacent to the traumatized area in order to ensure that the
basal membrane and lymphoid cells were intact and there-
fore expressing cytokines. Analysis by two different pa-
thologists, blind to each other’s findings, allowed us to
avoid inadequate necrotic areas and to choose the most rep-
resentative positive cells rather than false-positive granu-
lar histiocytes. Although computer-based image analyzers
offer more accurate digital quantification, these are not
available in many regional research centers, which are fre-
quently understaffed and poorly equipped; consequently,
we decided to establish a simple and reproducible method
using only an optical microscope.
The groups with no colitis presented macroscopic and
Table 5 - Association of necrosis and elevation of IFN-g and
IL-6 for the group with colitis at 24 hours, submitted to the
Fischer exact test
IFN-? IL-6
Necrosis Elevated Non-Elevated Elevated Non-elevated
Yes *4 0 *4 0
No 0 6 0 6
* Fischer exact test: P = .005
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histological alterations of little biological significance. This
was possibly due to local handling. The macroscopic study
of abdominal and colonic lesions in the groups with coli-
tis revealed severe alterations in comparison to the groups
without colitis, and became progressively more intense with
time (from 45 min to 24 h).
Among the cytokines studied (IL-1, IL-4, IL-6, TNF-?,
and IFN-?), TNF-? exhibited the highest levels of expres-
sion in all the groups and at both observation periods. The
same has been demonstrated in another animal model,47
where the production of TNF-? and the mRNA for this
cytokine were present in a model using macrophages from
the lamina propria of the colon in mice that were not sub-
mitted to colitis. In the same study, after colitis was induced
through TNBS, these macrophages increased the produc-
tion of TNF-? from 10 to 30 times when compared to the
controls,47 which was not observed in the present model of
acetic acid induced colitis. In a similar manner, Hirata et
al.48 failed to encounter an increased expression of TNF-?
in the inflamed mucosa of rats with colitis induced through
dextran sulfate. These observations indicate a possible in-
fluence of the aggressor agent over the type of cytokine
response generated by the immune system of the intestinal
mucosa in response to experimental colitis models; they are
reproduced in the clinical environment49. While some in-
vestigators demonstrated increased levels of TNF-? in IID
patients50-52, others detected no increase in cytokine expres-
sion in such patients39.
Using experimental models to analyze cytokine expres-
sion, other investigators have reported an increase in
TNF-?9. TNF-? is the first cytokine observed in any type of
local aggression, with a measurable manifestation within a
short period of time and peaking by 30 minutes.9 In the
cytokine cascade sequence, TNF-? stimulates and raises the
levels of IL-1 and IL-6.53,54 In our study, it is speculated that
the surgical procedure involving catheter introduction could
be responsible for elevated cellular TNF-?. In addition, al-
though no was observed difference in TNF-? expression be-
tween the different groups, IL-1 and IL-6, together with IFN-?,
presented elevated levels (45 min and 24 h post-infusion).
Our observations agree with the findings of Hirata et al.,48
who observed an increase in IL-1 without an increase in TNF-?
in the colonic mucosa of rats using a model of experimental
colitis induced through dextran sulfate. Specifically in rela-
tion to IL-1, the elevation in the expression of this cytokine
in the colonic tissue after 24 h in the WC group can be con-
sidered pertinent, since IL-1 initiates expression at 60 min-
utes post-aggression, peaks from 6 to 12 h, and can remain
elevated for up to 7 days.9,55 Our data also corroborates the
work by Khan et al.,56 who described constitutive expression
of RNAm for IL-1 in the colonic muscle of rats after endoanal
infusion of acetic acid (4%), which was significantly accen-
tuated at 1, 2, and 5 days, returning to normal levels on day
7 after induction of the disease.
In the present study, a direct association was found be-
tween the presence of necrosis and the elevation of IL-6
and IFN-? pro-inflammatory cytokines. These data support
the concept of efficacy of this colitis model as a means of
reproducing observations made on inflammatory bowel dis-
ease in humans, where the increase of these cytokines is
related to disease severity.57
In conclusion, the experimental model of acetic acid coli-
tis promotes tissue aggression capable of causing the pro-
duction of colonic cytokines. These cytokines exhibit a var-
ied profile of expression in the colon and are similar to those
found in lesions among inflammatory colitis patients, with
an increase in the expression of pro-inflammatory cytokines.
IL-6 and INF-? are adequate markers for the severity of ace-
tic acid colitis and are related to the presence of necrosis in
the colon. Immunohistochemical technique was efficient for
the analysis of IL-1 pro-inflammatory cytokine expression,
as well as IL-6 and IFN expression associated with the pres-
ence of colonic necrosis. This experimental model may be
used in short- and long-term assessment of the behavior of
different cytokines in different phases of colitis and poten-
tially to assist in the development of “anti-cytokine” thera-
pies to be used in the treatment of inflammatory bowel dis-
ease. Furthermore, prospective studies may include an ap-
proach involving computer analysis specially designed to
provide the cytokine profile of inflammatory cells.
ACKNOWLEDGEMENTS
This work was supported by the CNPQ (process nº
140925/00-7) and Fapesp (process nº 97/07971-70). The
authors thank Laboratório de Patologia CLASSE I for im-
munohistochemical assay.
284
CLINICS 2005;60(4):277-86Immunohistochemical assessment of mucosal cytokine profile
Bertevello PL et al.
RESUMO
Bertevello P, Logullo AF, Nonogaki S, Campos FM, Chiferi
V, Torrinhas CS et al. Avaliação imunohistoquímica do perfil
citocínico da mucosa colônica em colite experimental
induzida por ácido acético. Clinics. 2005;60(4):277-86.
O modelo de colite experimental induzida por ácido acético
(CEAA) vem sendo extensamente utilizado em estudos
sobre doenças inflamatórias intestinais (DII). Lesões no
tecido colônico em portadores de DII parecem estar
relacionados à produção local aumentada de citocinas pró-
inflamatórias (IL-1, IL-6, TNF-? e IFN-?).
OBJETIVO: Avaliar o padrão de expressão de citocinas
identificadas por imunohistoquímica em tecido colônico
após CEAA e relacioná-lo à presença de lesões
macroscópicas.
MATERIAL E MÉTODOS: Ratos machos Wistar adultos
(n=39) foram submetidos ou não à CEAA e sacrificados para
retirada do tecido colônico em dois períodos distintos,
perfazendo 4 grupos aleatórios: SC45 e SC24 (sem colite;
sacrifício 45 minutos e 24 horas, respectivamente); CC45
e CC24 (com colite; sacrifício 45 minutos e 24 horas,
respectivamente). Avaliaram-se alterações macro e
microscópicas do cólon e sua expressão de citocinas foi
avaliada por imunohistoquímica.
RESULTADOS: Após 24 horas, a expressão de IL-1 foi
maior no grupo com colite, em relação ao sem colite. IL-4
foi mais expressa no grupo CC45. Houve aumento de
INF-? e IL-6, relacionados à presença de necrose da mu-
cosa colônica, nos grupos com colite, em ambos os períodos
avaliados.
CONCLUSÃO: A técnica de imunohistoquímica foi eficiente
para a análise da expressão de citocinas na mucosa colônica.
Houve aumento da expressão das citocinas pró-inflamatórias
IL-1 e de IL-6 e IFN-? associado à presença de necrose
colônica. A CEAA é um bom modelo para o desenvolvimento
de estudos destinados a avaliar o papel das citocinas na
inflamação da mucosa e terapias anti-citocinas.
UNITERMOS: Citocinas. Ratos. Colite inflamatória.
Imunohistoquímica. Necrose.
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